GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Scientific Industries SCND · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.55

-6.78%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Scientific Industries

From its filings with the US Securities and Exchange Commission

SEC filings

Scientific Industries is based in Bohemia, New York and is incorporated in Delaware. Its shares trade on OTC under the ticker SCND. The SEC classifies its business as laboratory analytical instruments. In the fiscal year to 31 December 2025, it reported revenue of $5.1m and a net loss of $1.2m. At that date it held total assets of $12.6m and shareholders' equity of $10.7m.

In its own words

General. Incorporated in 1954, Scientific Industries, Inc., a Delaware corporation (“SI” and along with its subsidiaries, the “Company”), is engaged in the design, manufacture, and marketing of standard benchtop laboratory equipment (“Benchtop Laboratory Equipment”), and through its wholly-owned subsidiary, Scientific Bioprocessing Holdings, Inc., a Delaware corporation (“SBHI”), the design, manufacture, and marketing of bioprocessing systems and products (“Bioprocessing Systems”). SBHI has two wholly-owned subsidiaries – Scientific Bioprocessing, Inc., a Delaware corporation (“SBI”), and aquila biolabs GmbH, a German corporation (“Aquila”). The Company’s products are used primarily for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, and other industries performing laboratory-scale research. On August 7, 2025, the Company sold its Genie product line which was part of the Benchtop Laboratory Equipment operations but continues to market and produce scales and pill counters in the Benchtop Laboratory Equipment operating segment.

Quoted from its 10-K, filed 31 Mar 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
27 Oct 1993
Employees
55
Head office
70 ORVILLE DR, BOHEMIA, NY, 11716
Incorporated in
DE
Classification
Laboratory Analytical Instruments
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. John NicolsChairman of the Board, Chairman of SBI, since 2024$166,295
  • Ms. Helena SantosPresident, Chief Executive Officer, Treasurer, Director, since 1997$404,955
  • Mr. Zachary RovinskyChief Financial Officer
  • Mr. Daniel DonadilleChief Executive Officer - Bioprocessing Operations$336,572
  • Mr. Karl NowosielskiDirector of Marketing; President of the Torbal Products Division of the Benchtop Laboratory Equipment Operations$183,700
  • Mr. Robert NicholsCorporate Secretary; President of the Genie Products Division of the Benchtop Laboratory Equipment Operations$173,900
  • Mr. Michael BlechmanIndependent Director$33,658
  • Mr. Christopher CoxIndependent Director$40,798
  • Dr. Jurgen SchumacherIndependent Director$30,916

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Scientific Industries Inc possesses several key strengths that contribute to its success in the market. These strengths include:

Weaknesses

  • Despite its strengths, Scientific Industries Inc also faces certain weaknesses that can hinder its growth prospects. These weaknesses include:

Opportunities

  • Scientific Industries Inc can leverage several opportunities to expand its market presence and enhance profitability. These opportunities include:

Threats

  • Scientific Industries Inc faces certain threats in the market that may pose challenges to its operations. These threats include:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.